Peripheral Neuropathy clinical trials at UCLA

1 research study open to eligible people

Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients
open to eligible people ages 18 years and up
To evaluate the safety and tolerability of ART-123 in patients with metastatic colorectal cancer who receive oxaliplatin-containing chemotherapy and bevacizumab
Los Angeles, California and other locations

Last updated: November 7, 2023